Altamira Therapeutics Ltd to Host Investor & Business Update Call Transcript
Good morning, and welcome to Altamira Therapeutics December 23, 2023, investor business update conference call. On today's call is Thomas Meyer, Altamira Therapeutics, Founder, Chairman, and Chief Executive Officer. Earlier today, Altamira issued a news release providing a highlight of its business activities, which will be -- we will be discussing on this call. The release is available on the company's website at ir.altamiratherapeutics.com, and that's been filed with the SEC.
During today's call, the company will be making forward-looking statements within the meanings of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating financial business performance, strategies or expectations. Forward looking statements are based on the company's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements.
These risks and uncertainties include, but are not limited to, the timing and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |